Development of Quantitative Enzyme Immunoassay of Brain-Derived Neurotrophic Factor on the Basis of Recombinant Antigen


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

One of the pathophysiological mechanisms of the development of some mental diseases, including depressive disorders, is a decrease in the expression of brain-derived neurotrophic factor (BDNF), mainly in the limbic region and prefrontal cortex of the brain. Immunochemical screening of BDNF in biological fluids showed that the levels of this protein can be considered as a marker of predisposition to depression and a prognostic marker of the effectiveness of therapy. The use of modern technologies for the production of recombinant proteins makes it possible to develop highly standardized ELISA systems for the determination of this antigen in biological fluids. This paper describes a method for creating a test system for quantitative ELISA of brain-derived neurotrophic factor on the basis of recombinant protein BDNF and antibodies obtained as a result of immunization with recombinant BDNF.

About the authors

O. V. Pavlova

Serbsky National Medical Research Centre for Psychiatry and Narcology

Email: nchjournal@gmail.com
Russia, Moscow

A. A. Murashko

Moscow Research Institute of Psychiatry – the Branch of Serbsky
National Medical Research Centre for Psychiatry and Narcology

Email: nchjournal@gmail.com
Russia, Moscow

N. V. Andriushchenko

Serbsky National Medical Research Centre for Psychiatry and Narcology

Email: nchjournal@gmail.com
Russia, Moscow

O. I. Gurina

Serbsky National Medical Research Centre for Psychiatry and Narcology

Email: nchjournal@gmail.com
Russia, Moscow

K. A. Pavlov

Serbsky National Medical Research Centre for Psychiatry and Narcology

Email: nchjournal@gmail.com
Russia, Moscow

References

  1. Kessler R.C., Bromet E.J. // Annu. Rev. Public. Health. 2013. V. 34. P. 113–138.https://doi.org/10.1146/annurev-publhealth-031912-114409
  2. Stetler C., Miller G.E. // Psychosom. Med. 2011. V. 73. № 2. P. 114–126. https://doi.org/10.1097/PSY.0b013e31820ad12b
  3. Irwin M.R., Miller A.H. // Brain Behav. Immun. 2007 V. 21. № 4. P. 374–383. https://doi.org/10.1016/j.bbi.2007.01.010
  4. Григорьян Г.А., Дыгало Н.Н., Гехт А.Б., Степаничев М.Ю., Гуляева Н.В. // Усп. физиол. наук. 2014. Т. 43. № 2. С. 3–19.
  5. Sullivan P.F., Agrawal A., Bulik C.M., Andreassen O.A., Borglum A.D., Breen G., Cichon S., Edenberg H.J., Faraone S.V., Gelernter J., Mathews C.A., Nievergelt C.M., Smoller J.W., O’Donovan M.C. // Am. J. Psychiatry. 2018. V. 175. № 1. P. 15–27. https://doi.org/10.1176/appi.ajp.2017.17030283
  6. Yang T., Nie Z., Shu H., Kuang Y., Chen X., Cheng J., Yu S., Liu H. // Front. Cell Neurosci. 2020. V. 14. P. 82. https://doi.org/10.3389/fncel.2020.00082.eCollection 2020
  7. Barde Y.A., Edgar D., Thoenen H. // EMBO J. 1982. V. 1. № 5. P. 549–53.
  8. Kowianski P., Lietzau G., Czuba E., Waskow M., Steliga A., Morys J. // Cell Mol. Neurobiol. 2018. V. 38. P. 579–593.https://doi.org/10.1007/s10571-017-0510-4
  9. Гуляева Н.В. // Биохимия. 2017. Т. 82. Bып. 3. С. 441–448.
  10. Taliaz D., Stall N., Dar D.E, Zangen A.// Mol. Psychiatry. 2010. V. 15. № 1. P. 80–92. https://doi.org/10.1038/mp.2009.67
  11. Filho C.B., Jesse C.R., Donato F., Giacomeli R., Del Fabbro L., da Silva Antunes M., de Gomes M.G., Goes A.T., Boeira S.P., Prigol M., Souza L.C. // Neuroscience. 2015. V. 289. P. 367–380. https://doi.org/10.1016/j.neuroscience.2014.12.048
  12. Yoshida T., Ishikawa M., Niitsu T., Nakazato M., Watanabe H., Shiraishi T., Shiina A., Hashimoto T., Kanahara N., Hasegawa T., Enohara M., Kimura A., Iyo M., Hashimoto K. // PLoS One. 2012. V. 7. № 8. e42676. https://doi.org/10.1371/journal.pone.0042676
  13. Duman R.S., Aghajanian G.K., Sanacora G., Krystal J.H. // Nat. Med. 2016. V. 23. № 3. P. 238–249. https://doi.org/10.1038/nm.4050
  14. Duman R.S., Deyama S., Fogaça M.V. // Eur. J. Neurosci. 2021. V. 53. № 1. P. 126–139. https://doi.org/10.1111/ejn.14630
  15. Mondal A.C., Fatima M. // Int. J. Neurosci. 2019. V. 129. № 3. P. 283–296. https://doi.org/10.1080/00207454.2018.1527328
  16. Castren E., Kojima M. // Neurobiol. Dis. 2017. V. 97. P. 119–126. https://doi.org/10.1016/j.nbd.2016.07.010
  17. Nobis A., Zalewski D., Waszkiewicz N. // J. Clin. Med. 2020. V. 9. 3793. https://doi.org/10.3390/jcm9123793
  18. Islam F., Mulsant B.H., Voineskos A.N., Rajji T.K. // Curr. Psychiatry Rep. 2017. V. 19. № 7. P. 36. https://doi.org/10.1007/s11920-017-0794-6
  19. Song J.H., Yu J.T., Tan L. // Mol. Neurobiol. 2015. V. 52. № 3. P. 1477–1493. https://doi.org/10.1007/s12035-014-8958-4
  20. Nuernberg G.L., Aguiar B., Bristot G., Fleck M.P., Rocha N.S. // Transl. Psychiatry. 2016. V. 6. № 12. e985. https://doi.org/10.1038/tp.2016.227
  21. Jin W. // J. Clin. Med. 2020. V. 9. № 1. P. 257. https://doi.org/10.3390/jcm9010257

Supplementary files

Supplementary Files
Action
1. JATS XML
2.

Download (17KB)
3.

Download (74KB)
4.

Download (2MB)
5.

Download (28KB)

Copyright (c) 2023 О.В. Павлова, А.А. Мурашко, Н.В. Андрющенко, О.И. Гурина, К.А. Павлов